Advent International has acquired a majority stake in BioDuro, a pharmaceutical contract research and development organization (CRO) with operations in the US and China, from the Bridgewest Group conglomerate.
BioDuro provides fully integrated drug discovery and development services to biopharmaceutical manufacturers from initial target identification to manufacture of limited runs for clinical trials. It claims...
Investors see opportunity in bringing a promising currency exchange-focused fintech model from Europe into Southeast Asia. Singapore-focused YouTrip is the region’s first mover in this niche
Traditionally the overlooked, underappreciated or misrepresented facet of ESG, governance is gaining prominence in emerging markets private equity as investors reassess risk exposure
Capital has poured into China’s online education sector in recent years, but with losses mounting and valuations called into question, investors are finding that not all business models are created equal
Endiya Partners, an early-stage VC investor based in India, has achieved a first close of $40 million for its second fund. The target is $70 million.